SCHEMBL4833874

SCHEMBL4833874

CC(C)(C)c1ccc(C=NOCCCOc2ccc(C(=O)O)c(NC(=O)c3ccc(-c4ccccc4)cc3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 2/20 0.47
ALDH1A1 P00352 1/20 0.45
NR1H4 Q96RI1 5/20 0.45
PPARG P37231 2/20 0.45
PPARD Q03181 1/20 0.45
GPBAR1 Q8TDU6 1/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC2 Q92769 1/20 0.44
IGF2BP2 Q9Y6M1 1/20 0.43
MCHR1 Q99705 1/20 0.43
LMNA P02545 1/20 0.42
HCAR2 Q8TDS4 1/20 0.42
DHODH Q02127 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
POLB P06746 1/20 0.40
CASP3 P42574 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4833858 1.00 PLK1 (0.47) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4833302 0.95 PLK1 (0.52) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4833312 0.95 PLK1 (0.52) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4833885 0.93 ALDH1A1 (0.44) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4833876 0.93 ALDH1A1 (0.44) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4828963 0.92 PLK1 (0.46) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4828977 0.92 PLK1 (0.46) PLK1ALDH1A1NR1H4PPARGPPARD
SCHEMBL4825688 0.92 ACLY (0.47) PLK1HDAC1HDAC2IGF2BP2MCHR1
SCHEMBL4825675 0.92 ACLY (0.47) PLK1HDAC1HDAC2IGF2BP2MCHR1
SCHEMBL4833501 0.90 TRPM2 (0.48) HDAC1HDAC2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7420083-B2 Substituted aryloximes WYETH (US) 2008-09-02 US claimed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US claimed
US-20080293790-A1 SUBSTITUTED ARYL OXIMES WYETH (US) 2008-11-27 US disclosed
US-7420083-B2 Substituted aryloximes WYETH (US) 2008-09-02 US disclosed
US-20050070584-A1 Substituted aryloximes WYETH (US) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070584-A1 Substituted aryloximes AHR, NQO1, AOX1 PLK1 3639/4885ALDH1A1 269/4885NR1H4 1826/4885
US-20080293790-A1 SUBSTITUTED ARYL OXIMES HCCS, AOX1, TET2 PLK1 4185/4885ALDH1A1 211/4885NR1H4 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.